MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-11
DOI
10.1038/s41598-020-65331-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppressor miR-128-3p inhibits metastasis and epithelial–mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer
- (2018) Lili Zhao et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- An endogenous and ectopic expression of metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation and increases chemosensitivity of human neuroblastoma and glioma cells
- (2018) Danuta Jantas et al. CANCER LETTERS
- microRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis
- (2018) Qian Zhou et al. CANCER SCIENCE
- Long non-coding RNA LOC100507600 functions as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p in Hirschsprung's disease
- (2018) Yang Su et al. CELL CYCLE
- Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT)
- (2018) Jianlong Li et al. BMC Neurology
- C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview
- (2018) Wafaa M. Rashed CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
- (2018) Keren Weidenfeld et al. Frontiers in Oncology
- Roles of Notch1 Signaling in Regulating Satellite Cell Fates Choices and Postnatal Skeletal Myogenesis
- (2017) Tizhong Shan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer
- (2017) Wei-Wei Yu et al. Oncotarget
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models
- (2016) Yuji Piao et al. NEURO-ONCOLOGY
- miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
- (2015) Fotini M. Kouri et al. GENES & DEVELOPMENT
- Epigenetic Regulation of the lncRNA MEG3 and Its Target c-MET in Pancreatic Neuroendocrine Tumors
- (2015) Sita D. Modali et al. MOLECULAR ENDOCRINOLOGY
- miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE
- (2015) CHAO SHANG et al. Oncology Letters
- A phase I study of cabozantinib (XL184) in patients with renal cell cancer
- (2014) T. K. Choueiri et al. ANNALS OF ONCOLOGY
- Transforming Growth Factor- as a Therapeutic Target in Hepatocellular Carcinoma
- (2014) G. Giannelli et al. CANCER RESEARCH
- First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
- (2014) Jordi Rodon et al. CLINICAL CANCER RESEARCH
- Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128
- (2014) Yogita K Adlakha et al. Molecular Cancer
- KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway
- (2014) H Li et al. ONCOGENE
- A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer
- (2014) Maria E. Cabanillas et al. THYROID
- The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target
- (2013) C. Boccaccio et al. CANCER RESEARCH
- miR-128 and its target genes in tumorigenesis and metastasis
- (2013) Molin Li et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
- (2013) Pierpaolo Peruzzi et al. NEURO-ONCOLOGY
- The EMT regulator slug and lung carcinogenesis
- (2011) J.-Y. Shih et al. CARCINOGENESIS
- A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
- (2011) P. Y. Wen et al. NEURO-ONCOLOGY
- MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2010) Francesca Fornari et al. CANCER RESEARCH
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search